Green tea polyphenols and metabolites in prostatectomy tissue: Implications for cancer prevention

Cancer Prevention Research

Volumn 3, Issue 8, 2010, Pages 985-993

  Wang, Piwen ^a   Aronson, William J ^b   Huang, Min ^c   Zhang, Yanjun ^a   Lee, Ru Po ^a   Heber, David ^a   Henning, Susanne M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4'' O METHYLEPIGALLOCATECHIN 3 GALLATE; CASPASE 3; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ADULT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER LOCALIZATION; CANCER PREVENTION; CELL PROLIFERATION; CELL STRAIN LNCAP; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUGATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG STRUCTURE; GENETIC POLYMORPHISM; GLEASON SCORE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; METHYLATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; TEA; TREATMENT OUTCOME; TREATMENT RESPONSE; URINALYSIS;

ADENOCARCINOMA; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CHEMOPREVENTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMBINED MODALITY THERAPY; FLAVONOIDS; HUMANS; MALE; MODELS, BIOLOGICAL; PHENOLS; PLANT EXTRACTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TEA; TUMOR CELLS, CULTURED;

EID: 77955454869     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0210     Document Type: Article

References (39)

1. Suzuki J, Ogawa M, Futamatsu H, Kosuge H, Sagesaka YM, Isobe M. Tea catechins improve left ventricular dysfunction, suppress myocardial inflammation and fibrosis, and alter cytokine expression in rat autoimmune myocarditis. Eur J Heart Fail 2007;9:152-9. (Pubitemid 46402883)
2. Kalfon L, Youdim MB, Mandel SA. Green tea polyphenol (-)- epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection. J Neurochem 2007;100:992-1002. (Pubitemid 46213924)
3. Shen CL, Wang P, Guerrieri J, Yeh JK, Wang JS. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 2008;19:979-90.
4. Yuan JM, Gao YT, Yang CS, Yu MC. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int J Cancer 2007;120:1344-50.
5. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 1997;37:693-704.
6. Yokozawa T, Cho EJ, Hara Y, Kitani K. Antioxidative activity of green tea treated with radical initiator 2, 2′-azobis(2-amidinopropane) dihydrochloride. J Agric Food Chem 2000;48:5068-73.
7. Lin J, Della-Fera M, Baile C. Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-1 adipocytes. Obes Res 2005;13:982-90.
8. Hsu S, Farrey K, Wataha J, et al. Role of p21WAF1 in green tea polyphenol-induced growth arrest and apoptosis of oral carcinoma cells. Anticancer Res 2005;25:63-7. (Pubitemid 40470092)
9. Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H. Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 2003;22:4851-9. (Pubitemid 36981273)
10. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 2006;66:2500-5.
11. Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009;9:429-39.
12. Ohishi T, Kishimoto Y, Miura N, et al. Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane. Cancer Lett 2002;177: 49-56. (Pubitemid 34102398)
13. Jia XD, Han C. Chemoprevention of tea on colorectal cancer induced by dimethylhydrazine in Wistar rats. World J Gastroenterol 2000;6: 699-703.
14. Xiao H, Hao X, Simi B, et al. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis 2008;29:113-9. (Pubitemid 351201749)
15. Jian L, Xie LP, Lee AH, Binns CW. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 2004;108:130-5. (Pubitemid 37444455)
16. Kikuchi N, Ohmori K, Shimazu T, et al. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br J Cancer 2006;95:371-3. (Pubitemid 44187600)
17. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 2008;167:71-7.
18. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 2006;66:1234-40. (Pubitemid 43165995)
19. McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res 2009;2:673-82.
20. Yang CS, Lambert JD, Sang S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch Toxicol 2009;83:11-21.
21. Wang JS, Luo H, Wang P, et al. Validation of green tea polyphenol biomarkers in a phase II human intervention trial. Food Chem Toxicol 2008;46:232-40.
22. Meng X, Sang S, Zhu N, et al. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem Res Toxicol 2002;15: 1042-50.
23. Lu H, Meng X, Yang CS. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos 2003;31:572-9.
24. Henning SM, Niu Y, Lee NH, et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr 2004; 80:1558-64.
25. Yang GY, Liao J, Li C, et al. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 2000; 21:2035-9.
26. Lambert JD, Kwon SJ, Ju J, et al. Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate. Carcinogenesis 2008;29:2019-24.
27. Yang CS, Sang S, Lambert JD, Lee MJ. Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res 2008;52 Suppl 1:S139-51.
28. Henning SM, Aronson W, Niu Y, et al. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr 2006;136:1839-43.
29. Lee MJ, Maliakal P, Chen L, et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002;11: 1025-32.
30. Sang S, Lee MJ, Yang I, Buckley B, Yang CS. Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Commun Mass Spectrom 2008;22:1567-78.
31. Stalmach A, Troufflard S, Serafini M, Crozier A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol Nutr Food Res 2009;53 Suppl 1:S44-53.
32. Chen PC, Wheeler DS, Malhotra V, Odoms K, Denenberg AG, Wong HR. A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IκB kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation 2002;26:233-41.
33. Siddiqui IA, Shukla Y, Adhami VM, et al. Suppression of NFκB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharm Res 2008;25:2135-42.
34. Baldwin AS, Jr. Series introduction: the transcription factor NF-κB and human disease. J Clin Invest 2001;107:3-6.
35. Syed DN, Afaq F, Kweon MH, et al. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-κB activation in normal human bronchial epithelial cells. Oncogene 2007;26: 673-82.
36. Ishida I, Kohda C, Yanagawa Y, Miyaoka H, Shimamura T. Epigallocatechin gallate suppresses expression of receptor activator of NF-κB ligand (RANKL) in Staphylococcus aureus infection in osteoblast-like NRG cells. J Med Microbiol 2007;56:1042-6.
37. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006;4:221-33.
38. Landis-Piwowar KR, Wan SB, Wiegand RA, Kuhn DJ, Chan TH, Dou QP. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. J Cell Physiol 2007;213:252-60.
39. Wu AH, Tseng CC, Van Den Berg D, Yu MC. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 2003;63:7526-9.